Dr. Reddy's signs non-exclusive patent licensing agreement with Takeda to commercialise Vonoprazan

Merck and Orion announce option providing Merck global exclusive rights to Opevesostat

An investigational CYP11A1 Inhibitor, for the treatment of metastatic castration-resistant prostate cancer

Asahi Kasei Medical and AW Technologies enter exclusive distribution agreement for TrachFlush in Japan

UBE announces Phase I clinical trial for SSAO/VAP-1 licensed exclusively to Novo Nordisk

MASH is a chronic and progressive liver disease characterised by fat accumulation and inflammation in the liver,

Tata 1mg and Vitonnix UK get into an exclusive partnership in India

Launch innovative vitamin sublingual sprays

Glenmark and Cediprof inks exclusive distribution agreement in US

The agreement is for USFDA approved Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets

BSV receives exclusive marketing and distribution right for NexoBrid in India

To focus on providing safer burn treatments for women and armed forces

Zydus Lifesciences gets exclusive marketing rights for CanAssist Breast

Zydus becomes the only Indian oncology player to venture into prognosis and diagnosis along with treatment planning

Olympus announces exclusive U.S. co-marketing agreement with Bracco Diagnostics

The partnership will further strengthen Olympus leadership in the diagnosis and staging of liver disease

Juniper Biologics signs exclusive license agreement with Helsinn for infigratinib (INN) for the emerging markets including India

Infigratinib is not FDA-, Health Canada- or Therapeutics Goods Association-approved for any other indication